Market closedNon-fractional
Biora Therapeutics/BIOR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Biora Therapeutics
Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.
Ticker
BIOR
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
San Diego, United States
Employees
58
Website
www.bioratherapeutics.com
BIOR Metrics
BasicAdvanced
$24M
Market cap
-
P/E ratio
-$5.45
EPS
1.23
Beta
-
Dividend rate
Price and volume
Market cap
$24M
Beta
1.23
Financial strength
Current ratio
0.275
Quick ratio
0.228
Long term debt to equity
-43.78
Total debt to equity
-47.276
Interest coverage (TTM)
-6.78%
Management effectiveness
Return on assets (TTM)
-110.05%
Return on equity (TTM)
108.28%
Valuation
Price to revenue (TTM)
24.509
Price to book
-0.2
Price to tangible book (TTM)
-0.19
Price to free cash flow (TTM)
-0.272
Growth
Revenue change (TTM)
172.00%
Earnings per share change (TTM)
11.23%
3-year revenue growth (CAGR)
-67.93%
3-year earnings per share growth (CAGR)
-65.08%
What the Analysts think about BIOR
Analyst Ratings
Majority rating from 1 analysts.
BIOR Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$500K
∞%
Net income
-$4.1M
-73.38%
Profit margin
-820.00%
-∞%
BIOR Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$1.47
-$4.89
-$0.62
-$0.14
-
Expected
-$1.60
-$0.93
-$0.60
-$0.45
-$0.45
Surprise
-8.13%
428.65%
4.20%
-68.89%
-
BIOR News
AllArticlesVideos
Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next Gen Peptide Formulation & Delivery Summit 2024
GlobeNewsWire·1 month ago
Biora Therapeutics Presents Clinical Data on Device Function of the NaviCap™ Platform at Digestive Disease Week 2024
GlobeNewsWire·2 months ago
Biora Therapeutics, Inc. (BIOR) Q1 2024 Earnings Call Transcript
Seeking Alpha·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Biora Therapeutics stock?
Biora Therapeutics (BIOR) has a market cap of $24M as of July 27, 2024.
What is the P/E ratio for Biora Therapeutics stock?
The price to earnings (P/E) ratio for Biora Therapeutics (BIOR) stock is 0 as of July 27, 2024.
Does Biora Therapeutics stock pay dividends?
No, Biora Therapeutics (BIOR) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Biora Therapeutics dividend payment date?
Biora Therapeutics (BIOR) stock does not pay dividends to its shareholders.
What is the beta indicator for Biora Therapeutics?
Biora Therapeutics (BIOR) has a beta rating of 1.23. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Biora Therapeutics stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.